Mediterranean Diet and IVF: Better Odds, Not a Guarantee

Fertility supplements get the glossy packaging. Whole-food eating has the better evidence signal—though it still falls short of proof that changing your diet will raise your IVF live-birth rate.

A 2023 meta-analysis pooled 11 observational studies of women undergoing assisted reproductive technology (ART). Women with higher adherence to Mediterranean-type dietary patterns had 1.91 times the odds of live birth or clinical pregnancy compared with women with lower adherence. The result came from Winter et al.'s systematic review and meta-analysis, the largest quantitative synthesis in this area.

That is a meaningful association, but it is not a promise. If an IVF program's baseline live-birth rate were 30%, an odds ratio of 1.91 converts to an estimated probability near 45%; at a 40% baseline, it converts to roughly 56%. Those are mathematical projections from an observational association, not results from a trial in which researchers assigned patients to a diet. Odds ratios also look larger than relative risks when outcomes are common, and IVF live-birth rates commonly fall in the 30% to 40% range per cycle.

The pattern matters more than the capsule

The diets grouped in the meta-analysis had a recognizable structure. Mediterranean, ProFertility, Dutch dietary-guideline, and similarly derived "healthy" patterns emphasized vegetables, fruit, legumes, whole grains, olive oil, fish, and lower intake of red and processed meat and refined carbohydrates. The studies used different scoring systems, but they pointed in the same dietary direction.

That consistency matters more than a claim that olive oil, blueberries, or any other single food has a special fertility switch. Diets are bundles: they affect fiber intake, fat quality, metabolic health, and the overall displacement of ultra-processed foods. They also travel with other behaviors. People who score highly on Mediterranean-style eating often have different income, activity, smoking, and body-weight patterns than people who do not. Those differences can help explain an apparent diet effect even after statistical adjustment.

Two other reviews support the direction of the association. Kellow et al.'s 2022 systematic review and meta-analysis examined dietary patterns and ART outcomes in both women and men, while Sanderman et al.'s IVF-focused systematic review found favorable female dietary patterns repeatedly associated with better IVF outcomes. Overlapping evidence does not turn association into causation, but it makes a one-study fluke less likely.

Why the estimate needs a warning label

All 11 studies in Winter et al.'s pooled estimate were observational; the review excluded randomized controlled trials. Participants generally reported diet through food-frequency questionnaires or 24-hour recalls. Those methods can miss foods, misjudge portions, and invite a little aspirational reporting. Few people remember every snack with the accuracy of a forensic accountant.

The pooled outcome also included live birth and clinical pregnancy. Those endpoints are related but not interchangeable: clinical pregnancy occurs earlier, while live birth is the patient outcome that matters most. The available report does not provide a single standardized dietary intervention, a minimum time on the diet, or complete subgroup results by infertility diagnosis, age, or BMI. It also pooled populations across countries, ART protocols, and dietary scores. The review assessed heterogeneity and publication bias, but the available published extract does not report the relevant I², Egger regression, or sensitivity relative-risk values.

Even the label "Mediterranean diet" deserves caution. A 2026 prospective cohort study of Sicilian women undergoing ART reported declining adherence in a region where the diet originated. If real-world adherence varies this much, scoring a person as "high adherence" can mean somewhat different things across clinics and countries.

Plausible biology, but not a completed causal case

The biology is credible without being conclusive. A 2025 systematic review of polyphenol intake and female ART outcomes linked higher polyphenol intake with improved ART outcomes. Polyphenols occur in many foods common in Mediterranean-style eating, including olive oil, legumes, berries, and whole grains. The review discussed antioxidant and anti-inflammatory pathways that could affect the follicular and reproductive environment.

Those pathways are hypotheses supported by related evidence, not proof that polyphenols cause higher live-birth rates. Likewise, a 2024 prospective cohort study found that greater Mediterranean-diet adherence was associated with better blastocyst formation in women previously infected with COVID-19. Blastocyst formation is clinically relevant, but it is an intermediate IVF outcome—not a live birth—and the study population was specific.

The diet signal also involves both partners. In a prospective cohort at an academic fertility center, Salas-Huetos et al. assessed pretreatment diet in 245 men whose couples underwent 438 ART cycles between 2007 and 2020. The study examined eight cardiovascular-oriented diet scores, semen parameters, and ART outcomes, including live birth per treatment cycle. Healthier paternal dietary patterns were associated with better sperm parameters and better couple-level ART outcomes. It does not establish that a male partner can change the outcome of the next cycle by changing lunch next Tuesday, but it is a reason to stop treating fertility nutrition as a women-only assignment.

Supplements have not earned the same confidence

This does not mean every supplement is useless. It means the evidence does not support treating a supplement stack as a proven substitute for diet quality. A 2026 systematic review and meta-analysis of micronutrients concluded that evidence on reproductive outcomes and aneuploidy remains uncertain and cannot support firm clinical recommendations.

The randomized trial in this evidence base does not close that gap. Kelley et al.'s 2025 randomized controlled trial tested antioxidants added to IVF and embryo culture media for fresh blastocyst transfers. Culture-media antioxidants are not oral supplements and are certainly not a Mediterranean diet. Its randomized design makes it useful for its narrow laboratory intervention, but it cannot confirm or refute the observational dietary-pattern finding.

One more caution concerns diet drinks. A retrospective cohort of 840 women, alongside animal and cell experiments, linked frequent aspartame-containing diet-drink consumption with oocyte dysmorphism, poorer embryo quality, and worse pregnancy outcomes. In younger women, aspartame consumption was associated with infertility risk at an odds ratio of 1.79 (95% CI, 1.00–3.22) in Chen et al.'s 2022 study. The confidence interval reaches the null, and the human evidence was observational, so this cannot quantify the harm caused by a diet soda. It is a reasonable reason to reduce frequent intake, not a reason to panic over an occasional can.

What to put on the plate before ART

A Mediterranean-style default is a sensible, low-risk choice during ART preparation: vegetables and fruit most days; beans and whole grains often; olive oil as a main added fat; fish regularly; and less red meat, processed meat, refined carbohydrates, and ultra-processed food. Include the male partner. Maintain prescribed prenatal folate and any clinician-directed treatment; this evidence does not replace them.

The honest claim is narrow: Mediterranean-type eating is consistently associated with better ART outcomes, while controlled trials have not shown that adopting it causes a higher live-birth rate.

No study here defines how many weeks or months of adherence are needed, how strict the pattern must be, or whether it works differently in PCOS, endometriosis, or unexplained infertility. For now, food is the more evidence-aligned foundation than an expensive fertility supplement routine—but it remains a foundation, not a guarantee.